Research interests are in theoretical, basic, and clinical aspects of the pharmacokinetics and pharmacodynamics of various immunosuppressive agents including corticosteroids, as well as drugs used to treat diabetes, inflammation, and cancer. With Drs. Richard Almon and Debra DuBois, Dr. Jusko delves into the pharmacogenomics of diverse effects of corticosteroids and has evolved advanced mathematical models of receptor/gene-mediated responses. They have characterized the effects of corticosteroids on hepatic and muscle enzymes and tissue responses and have evolved advanced PK/PD models for cascade-type processes. Dr. Jusko has developed mechanism-based pharmacokinetic, pharmacodynamic, and disease progression models and computational methods describing the action of various drugs and utilizes mathematical models of drug action to determine optimal dosage regimens diverse drugs.
Education and Training:
PhD, Pharmaceutical Sciences, State University of New York at Buffalo (1970)
BPharm, State University of New York at Buffalo (1965)
Secondary Education High School Diploma, Salamanca High School (1960)
Employment:
SUNY Distinguished Professor, Pharmaceutical Sciences, University at Buffalo (2008-present)
Director, Center of Excellence in Pharmacokinetics and Pharmacodynamics, Pharmaceutical Sciences, University at Buffalo (2005-present)
Chair, Department of Pharmaceutical Sciences, University at Buffalo (2001–2016)
UB Distinguished Professor, Department of Pharmaceutical Sciences, University at Buffalo (2007–2008)
Professor, Pharmaceutical Sciences, University at Buffalo (1977–2007)
Vice-Chairman, Department of Pharmacy, Department of Pharmacy, University at Buffalo (1984–1986)
Director, Doctor of Pharmacy Program, Pharmacy, University at Buffalo (1981–1986)
AAPS Distinguished Pharmaceutical Scientist Award (2020)
Lewis B. Sheiner Pharmacometrics Award, ISoP (2019)
ASCPT Oscar B. Hunter Career Award (2018)
ASCPT/FDA William Abrams Lecture Award (2017)
Fellow, International Society of Pharmacometrics (2016)
Advisor: AAPS Graduate Student Award in PPDM - Xu Zhu and Xi (Cindy) Chen (2015)
Doctor Honoris Causae, University of Paris Descartes (2015)
Collegium of Eminent Scientists, Kosciuszko Foundation (2015)
ASCPT Sheiner-Beal Pharmacometrics Award (2013)
Advisor: AAPS Graduate Student Award in PPDM - Hoi Kei Lon (2012)
Distinguished Investigator Award ACCP (2012)
ACoP Leadership Award (2011)
AAPS Meritorious Manuscript Award (2008)
Paul Ehrlich Magic Bullet Lifetime Achievement Award (2008)
UB Distinguished Professor (2007)
Swintosky Distinguished Lecturer - UKY (2006)
Volwiler Research Achievement Award - AACP (2005)
MERIT Award - NIH (2005)
Roland T. Lakey Award Lecture - WS (2003)
ISI Most Highly Cited List in Pharmacology (2003)
Chancellor‘s Award for Research -UB (2003)
Sustained Achievement Award - UB (2002)
John G. Wagner Lectureship - UM (1999)
Research Achievement Award - PPDM, AAPS (1998)
Kosciusko Award - Buffalo (1996)
Distinguished Service Award - ACCP (1989)
Russell R. Miller Award - ACCP (1988)
Doctor Honoris Causae, Jagiellonian University, Krakow (1987)
Citizen of the Year - Buffalo (1987)
Rawls-Palmer Award - ASCPT (1987)
Fellow- AAPS (1986)
Fellow - ACCP (1986)
Fellow - AAAS (1985)
Rorer Award - AJG (1980)
Fellow - ACS (1980)
Fulbright-Hays Award to lecture/research in Milan, Italy (1978)
Research Expertise:
Pharmacodynamics: Pharmacogenomics of diverse effects of corticosteroids and the development of models of receptor/gene-mediated responses
Pharmacokinetics and Pharmacodynamics: Theoretical, basic, and clinical aspects of the PK/PD of immunosuppressive agents including corticosteroids, sirolimus, and tacrolimus
Grants and Sponsored Research:
August 2015–August 2019 Buffalo Clinical and Translational Research Center Clinical and Translational Science Award(CTSA) National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health Role: Co-Investigator $20,000,000
July 2015–June 2019 Corticosteroid Pharmacokinetics and Pharmacodynamics NIH/NIGMS Role: Principal Investigator $2,392,890
September 2014–August 2017 Physiologically-Based Pharmacokinetic Model for Drugs Encapsulated into Liposomes NIH/FDA Role: Co-Investigator $639,400
September 2011–August 2016 Molecular and Clinical Pharmacology of Retinopathy of Prematurity NIH/NICHHD Role: Co-Investigator $79,020
June 2012–August 2013 Pharmacokinetics and Relative Bioavailability of Liquid Formulation of Hydroxyurea in Pediatric Patients with Sickle Cell Anemia Duke University Role: Principal Investigator $19,439
Zhu X, Shen X, Qu J, Straubinger RM, Jusko WJ.. Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells. CPT Pharmacometrics Syst Pharmacol.. 2018.
Song D, Dubois DC, Almon RR, Jusko WJ. Modeling Sex Differences in Anti-inflammatory Effects of Dexamethasone in CIA Rats. Pharmaceutical Research. 2018; 35(203).
Liu D; Lon H; Wang Y; Dubois DC; Almon RR; Jusko WJ. Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen-induced arthritic rats. Biopharmaceutics & Drug Disposition. 2013; 34.
Dubois DC; Sukumaran S; Jusko WJ; Almon RR. Evidence for a Glucocorticoid Receptor Beta Splice Variant in the Rat and Its Physiological Regulation in Liver Steroids. Steroids. 2013; 78.
Fang J; Landersdorfer CB; Cirincione B; Jusko WJ. Study Reanalysis Using a Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes. AAPSJ. 2013; 15.
Sukumaran S; Lepist E; Dubois DC; Almon RR; Jusko WJ. Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone Effects on iNOS mRNA Expression and Nitric Oxide During LPSInduced Inflammation in Rats. Pharmaceutical Research. 2012; 29.
Cao Y; Dubois DC; Almon RR; Jusko WJ. Pharmacokinetics of salsalate and salicylic acid in normal and diabetic rats. Biopharmaceutics & Drug Disposition. 2012; 33.
Jusko WJ. Use of Pharmacokinetic Data Below Lower Limit of Quantitation Values. Pharmaceutical Research. 2012; 29.
Landersdorfer CB; He Y; Jusko WJ. Mechanism-Based Population Modelling of the Effects of Vildagliptin on GLP-1, Glucose and Insulin in Patients with Type 2 Diabetes. British Journal of Clinical Pharmacology. 2012; 73.
MA,ller JB; Jusko WJ; Gao W; Hansen T; Pedersen O; Holst JJ; Overgaard RV; Madsen H; Ingwersen SH. Mechanism-Based Population Modelling for Assessment of L-Cell Function Based on Total GLP-1 Response Following an Oral Glucose Tolerance Test. Journal of Pharmacokinetics and Pharmacodynamics. 2011; 38.
Nie J; Bai B; Sukumaran S; Jusko WJ; Dubois DC; Almon RR. Differential Muscle Gene Expression as a Function of Disease Progression in Goto-Kakizaki Diabetic Rats. Molecular and Cellular Endocrinology. 2011; 338.
Sukumaran S; Jusko WJ; Dubois DC; Almon RR. MECHANISTIC MODELING OF THE EFFECTS OF GLUCOCORTICOIDS AND CIRCADIAN RHYTHMS ON ADIPOKINE EXPRESSION. J. Pharmacol. Exp. Ther.. 2011; 337.
Lon H; Liu D; Zhang Q; Dubois DC; Almon RR; Jusko WJ. Pharmacokinetic-Pharmacodynamic Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis. Pharmaceutical Research. 2011; 28.
Gao W; Jusko WJ. Pharmacokinetic and Pharmacodynamic Modeling of Exendin-4 in Type 2 Diabetic Goto-Kakizaki Rats. THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2011; 336.
Scheff JD; Almon RR; Dubois DC; Jusko WJ; Androulakis IP. Assessment of Pharmacologic Area Under the Curve when Baselines are Variable. Pharmaceutical Research. 2011; 28.
Nie J; Dubois DC; Jusko WJ; Almon RR. Mechanistic Population Modeling of Diabetes Disease Progression in Goto-Kakizaki Rat Muscle. BIOPHARMACEUTICS & DRUG DISPOSITION. 2011; 32.
Sukumaran S; Xue B; Jusko WJ; Dubois DC; Almon RR. Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology. Physiol Genomics. 2010; 42A.
Jusko WJ; Ziegler A; Chatenoud C; Waldmann H; Hale G; Rebello P; Al Bakir I; Bolam E; Wiczling P; Vandemeulebroucke E; Keymeulen B; Mathieu C. Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes. The Journal of Clinical Pharmacology. 2010; 50.
Scheff JD; Almon RR; Dubois DC; Jusko WJ; Androulakis IP. A New Symbolic Representation for the Identification of Informative Genes in Replicated Microarray Experiments. OMICS A Journal of Integrative Biology. 2010; 14.
Sukumaran S; Almon RR; Dubois DC; Jusko WJ. Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. Advanced Drug Delivery Reviews. 2010; 62.
Nguyen TT; Almon RR; Dubois DC; Jusko WJ; Androulakis IP. Comparative Analysis of Acute and Chronic Corticosteroid Pharmacogenomic Effects in Rat Liver: Transcriptional Dynamics and Regulatory Structures. BMC Bioinformatics. 2010; 11.
Landersdorfer CB; Jusko WJ. Pharmacokinetic/Pharmacodynamic Modeling of Glucose Clamp Effects of Inhaled and Subcutaneous Insulin in Healthy Volunteers and Diabetic Patients. Drug Metab. Pharmacokinet.. 2010; 25.
Ghoshal S; Rao I; Earp JC; Jusko WJ; Wetzler M. Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity. Cancer Chemotherapy Pharmacology. 2010; 66.
Nguyen TT; Almon RR; Dubois DC; Jusko WJ; Androulakis IP. Importance of replication in analyzing time-series gene expression data: Corticosteroid dynamics and circadian patterns in rat liver. BMC Bioinformatics. 2010; 11.
Wiczling P; Rosenzweig M; Vaickus L; Jusko WJ. Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects with Psoriasis and with Type 1 Diabetes Mellitus. Journal of Clinical Pharmacology. 2010; 50.
Cho H; Blum RA; Sunderland T; Cooper GJ; Jusko WJ. Pharmacokinetic and Pharmacodynamic Modeling of a Copper-Selective Chelator (TETA) in Healthy Adults. The Journal of Clinical Pharmacology. 2009; 49.
Almon RR; Dubois DC; Lai W; Xue B; Nie J; Jusko WJ. Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats.. J Endocrinol. 2009; 200.
Landersdorfer CB; Dubois DC; Almon RR; Jusko WJ. Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats.. J Pharmacol Exp Ther. 2009; 328.
Bulitta JB; Ly NS; Yang JC; Forrest A; Jusko WJ; Tsuji BT. Development and Qualification of a Pharmacodynamic Model for the Pronounced Inoculum Effect of Ceftazidime against Pseudomonas aeruginosa. Antimicrob. Ag. Chemother.. 2009; 53.
Earp JC; Dubois DC; Almon RR; Jusko WJ. Quantitative dynamic models of arthritis progression in the rat.. Pharm Res. 2009; 26.
Rohatagi S; Carrothers TJ; Jin J; Jusko WJ; Khariton T; Walker J; Truitt K; Salazar DE. Model-Based Development of a PPAR-gamma Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs. J Clin Pharmacol. 2008; 48.
Yao Z; Dubois DC; Almon RR; Jusko WJ. Pharmacodynamic/Pharmacogenomic Modeling of Insulin Resistance Genes in Rat Muscle After Methylprednisolone Treatment: Exploring Regulatory Signaling Cascades. Gene Reg. Sys. Biol.. 2008; 2.
Almon RR; Yang E; Lai W; Androulakis IP; Ghimbovschi S; Hoffman EP; Jusko WJ; Dubois DC. Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle.. Am J Physiol Regul Integr Comp Physiol.. 2008; 295.
Almon RR; Yang E; Lai W; Androulakis IP; Dubois DC; Jusko WJ. Circadian variations in rat liver gene expression: relationships to drug actions.. J Pharmacol Exp Ther. 2008; 326.
Earp JC; Dubois DC; Molan DS; Pyszcznski NA; Keller CE; Almon RR; Jusko WJ. Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats. J. Pharmacol. Exp. Ther.. 2008; 326.
Earp JC; Dubois DC; Molano DS; Pyszczynski NA; Almon RR; Jusko WJ. Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis.. J Pharmacol Exp Ther.. 2008; 326.
Yang E; Almon RR; Dubois DC; Androulakis IP; Jusko WJ. Extracting global system dynamics of corticosteroid genomic effects in rat liver. J Pharmacol Exp Ther. 2008; 324.
Hazra A; Dubois DC; Almon RR; Snyder GS; Jusko WJ. Pharmacodynamic Modeling of Acute and Chronic Effects of Methylprednisolone on Hepatic Urea Cycle Genes in Rats. Gene Regulation and Systems Biology. 2008; 2.
Woo S; Krzyzanski W; Jusko WJ. Pharmacodynamic model for chemotherapy-induced anemia in rats. Cancer Chem. Pharmacol.. 2008; 62.
Woo S; Krzyzanski W; Duliege A; Stead RR; Jusko WJ. Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers. J. Clin. Pharmacol.. 2008; 48.
Hazra A; Pyszczynski NA; Dubois DC; Almon RR; Jusko WJ. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids. J Pharmacokinet Pharmacodyn. 2007; 34.
Woo S; Krzyzanski W; Jusko WJ. Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). J. Pharmacokin. Pharmacodyn.. 2007; 34.
Yao Z; Dubois DC; Almon RR; Jusko WJ. Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats. J Pharm Sci. 2007; 97.
Hazra A; Dubois DC; Almon RR; Jusko WJ. Assessing the Dynamics of Nuclear Glucocorticoid-Receptor Complex: Adding Flexibility to Gene Expression Modeling. J. Pharmacokin. Pharmacodyn.. 2007; 34.
Hong Y; Mager DE; Blum RA; Jusko WJ. Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: Modeling interoccasion pharmacodynamic variability. Pharm Res. 2007; 24.
Almon RR; Dubois DC; Yao Z; Hoffman EP; Ghimbovschi S; Jusko WJ. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiol Genomics. 2007; 30.
Yao Z; Zhao B; Hoffman EP; Ghimbovschi S; Dubois DC; Almon RR; Jusko WJ. Application of Scaling Factors in Simultaneous Modeling of Microarray Data from Diverse Chips. Pharm. Res.. 2007; 24.
Almon RR; Dubois DC; Jusko WJ. A Microarray Analysis of the Temporal Response of Liver to Methylprednisolone: A Comparative Analysis of Two Dosing Regimens. Endocrinology. 2007; 148.
Woo S; Krzyzanski W; Jusko WJ. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.. Journal of Pharmacology and Experimental Therapeutics. 2006; 319.
Yao Z; Krzyzanski W; Jusko WJ. Assessment of basic indirect pharmacodynamic response models with physiological limits.. Journal of Pharmacokinetics and Pharmacodynamics. 2006; 33.
Krzyzanski W; Woo S; Jusko WJ. Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans.. Journal of Pharmacokinetics and Pharmacodynamics. 2006; 33.
Mager DE; Lin SX; Blum RA; Lates CD; Jusko WJ. Dose equivalency evaluation of major corticosteroids: Pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol. 2003; 43.
Almon RR, Chen J, Snyder G, DuBois DC, Jusko WJ, Hoffman EP. In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR).. Pharmacogenomics. 2003; 4(6).
Sutfin TA, Perini GI, Molnar G, Jusko WJ. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.. J Clin Psychopharmacol. 1988; 8(1).
Morphy MA, Fava GA, Carson SW, Perini GI, Molnar G, Jusko WJ. The metyrapone test in schizophrenic patients and healthy subjects.. Neuropsychobiology. 1985; 14(1).
Perini GI, Fava GA, Morphy MA, Carson SW, Molnar G, Jusko WJ. The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment.. J Affect Disord. 1984; 7(3-4).
Fava GA, Carson SW, Perini GI, Morphy MA, Molnar G, Jusko WJ. The metyrapone test in affective disorders and schizophrenia.. J Affect Disord. 1984; 6(3-4).
Perini GI, Fava GA, Morphy MA, Carson SW, Molnar G, Jusko WJ. The metyrapone test in manic patients and healthy subjects.. Pharmacopsychiatry. 1984; 17(3).
Milsap RL, George DE, Szefler SJ, Murray KA, Lebenthal E, Jusko WJ. Effect of inflammatory bowel disease on absorption and disposition of prednisolone.. Dig Dis Sci. 1983; 28(2).
Szefler SJ, Brenner M, Jusko WJ, Spector SL, Flesher KA, Ellis EF. Dose- and time-related effect of troleandomycin on methylprednisolone elimination.. Clin Pharmacol Ther. 1982; 32(2).
Szefler SJ, Ellis EF, Brenner M, Rose JQ, Spector SL, Yurchak AM, Andrews F, Jusko WJ. Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy.. J Allergy Clin Immunol. 1982; 69(5).
Lima JJ, Conti DR, Goldfarb AL, Tilstone WJ, Golden LH, Jusko WJ. Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.. J Pharmacokinet Biopharm. 1979; 7(1).
Lima JJ, Goldfarb AL, Conti DR, Golden LH, Bascomb BL, Benedetti GM, Jusko WJ. Safety and efficacy of procainamide infusions.. Am J Cardiol. 1979; 43(1).
Jusko WJ, Schentag JJ, Clark JH, Gardner M, Yurchak AM. Enhanced biotransformation of theophylline in marihuana and tobacco smokers.. Clin Pharmacol Ther. 1978; 24(4).
Koup JR, Jusko WJ, Goldfarb AL. pH-dependent secretion of procainamide into saliva.. J Pharm Sci. 1975; 64(12).
Koup JR, Greenblatt DJ, Jusko WJ, Smith TW, Koch-Weser J. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.. J Pharmacokinet Biopharm. 1975; 3(3).
Jusko WJ. Foundations of Pharmacodynamic Systems Analysis (Chapter 8). Systems Pharmacology and Pharmacodynamics, AAPS Advances in the Pharmaceutical Sciences Series 23. 2016.
Cao Y Jusko WJ. Mechanistic Physiologically Based Pharmacokinetic Models in Development of Therapeutic Monoclonal Antibodies (Chapter 12). ADME and Translational PK/PD of Therapeutic Proteins. 2015; Chpt(12).
"3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics" Annual 3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics, SUNY AT BUFFALO, PHC DEPARTMENT (2018)
"3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics" Annual 3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics, SUNY AT BUFFALO, PHC DEPARTMENT (2017)
"3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics" 3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics (2016)
"Multiscale PD Studies of Drug Combination Between Gemcitabine & Trabectedin for the Treatment of Pancreatic Cancer. Scale III. Dynamic Proteomic Responses of Pancreatic Cancer Cells Druing Combination Exposures to Gemcitabine & Trabectedin" Roche ‘Increasing Drug Development Success Through Quantitative Systems Pharmacology’, NY Academy of Sciences Symposium (2015)
"Multiscale Pharmacodynamic (PD) Studies of Drug Combination Between Gemcitabine & Trabectedin for the Treatment of Pancreatic Cancer. Scale II. Mathematical Models of Cell Cycle Distribution of Gemcitabine, Trabectidin & Combinations on Pancreatic Cancer" Roche ‘Increasing Drug Development Success Through Quantitative Systems Pharmacology’, New York Academy of Sciences Symposium (2015)
"Network Analysis of Proteomics of Gemcitabine and Birinapant Combinations in Apoptosis Signaling of Pancreatic Cancer Cells" Roche ‘Increasing Drug Development Success Through Quantitative Systems Pharmacology’, New York Academy of Sciences Symposium (2015)
"Dynamic Proteomic Responses of Pancreatic Cancer Cells During Combination Exposures to Gemcitabine and Ecteinascidin ET 743" American Association of Pharmaceutical Scientists (2015)
"Mechanistic Modeling of Tissue-Specific Receptor/Gene-Mediated Pharmacodynamic Effects of Corticosteroids and Role of Circadian Rhythms on GILZ mRNA Expression" American Association of Pharmaceutical Scientists (2015)
"Minimal Physiologically-Based Pharmacokinetic (mPBPK) Model for a Monoclonal Antibody (mAb) against Interleukin-6 in Mice with Collagen-Induced Arthritis (CIA)”" American Conference on Pharmacometrics (2015)
"Multiscale Pharmacodynamic Studies of Gemcitabine and Trabectedin Combinations for Treatment of Pancreatic Cancer" Department of Pharmaceutical Sciences, 323266818 (2015)
"Network Analysis of Proteomics of Gemcitabine and Birinapant Combinations in Pancreatic Cancer Cells" American Association of Pharmaceutical Scientists (2015)
"Pharmacodynamics of Suppression of Free TNF-a by Infliximab in Plasma of Rats" American Association of Pharmaceutical Scientists (2015)
"What We Do in Pharmaceutical Sciences" University of Buffalo - PharmD IPPE program, 323266818 (2015)
"Moving From Basic PK/PD Towards Systems Pharmacology: Whither Pediatrics?" T32 Programs in Pediatric Clinical Pharmacology, National Institute of Child Health and Human Development (2015)
"Moving From Basic Towards Systems Pharmacodynamic Models" Faculte de Pharmacie de Paris, Universite Paris Descartes (2015)
"Inclusion of Tissue Target Dynamics in Minimal PBPK Models for mAb PK/PD" Seventh Annual Symposium, Center for Protein Therapeutics, 323266818 (2015)
"Suppression of Free TNF-a With Infliximab in Plasma and Joints in CIA Rats" Seventh Annual Symposium, Center for Protein Therapeutics, 323266818 (2015)
"3-day course on Pharmacokinetic-Pharmacodynamic Modeling" Merck Pharmaceuticals (2015)
"Transitioning From Basic PK/PD To Systems Pharmacology" NJ/PA Branch of the International Society for Pharmacometrics (2015)
"Effects of Altered FcgR Expression by Dexamethasone on Monoclonal Antibody Pharmacokinetics in Rats with Rheumatoid Arthritis" 7th Annual Postdoc Research Symposium, 323266818 (2015)
"Annual 3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics" Annual 3-day Buffalo Post-Graduate Course on Pharmacokinetics and Pharmacodynamics (2015)
"PBPK Modeling of Etanercept Biodistribution in Arthritic Rats" Department of Pharmaceutical Sciences, 323266818 (2015)
"Two-Day Buffalo Workshop on Systems Pharmacology" Two-Day Buffalo Workshop on Systems Pharmacology, 323266818 (2015)
"Network Analysis of Proteomics of Gemcitabine and Birinapant Combinations in Apoptosis Signaling of Pancreatic Cancer Cells" UB Sigma Xi Poster Day, 323266818 (2015)
"Network Modeling of Gemcitabine and Birinapant Proteomics in Pancreatic Cancer Cells" Department of Pharmaceutical Sciences, 323266818 (2015)
"Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model" AAPS Annual Meeting and Exposition (2014)
"Biodistribution of Etanercept to Tissues and Sites of Inflammation in Arthritic Rats" American Association of Pharmaceutical Scientists (2014)
"Incorporating Target-Mediated Drug Disposition in a Minimal Physiologically-Based Pharmacokinetic Model for Monoclonal Antibodies" AAPS Annual Meeting and Exposition (2014)
"Mechanism-Based Drug Interactions of Gemcitabine and Birinapant in Pancreatic Cancer Cells" AAPS Annual Meeting and Exposition (2014)
"Second-Generation Minimal Physiologically-Based Pharmacokinetic Model for Monoclonal Antibodies" American Association of Pharmaceutical Scientists (2014)
"Department Highlights” and “Moving from Basic towards Systems Pharmacodynamic Models" Thirteenth Buffalo Pharmaceutics Symposium, 323266818 (2014)
"Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model" Thirteenth Buffalo Pharmaceutics Symposium, 323266818 (2014)
"Mechanism-Based Interaction Model of Gemcitabine and Ecteinascidin (Et-743) in Pancreatic Cancer Cells" Thirteenth Buffalo Pharmaceutics Symposium, 323266818 (2014)
"Mechanism-Based Drug Interactions of Gemcitabine and Birinapant in Pancreatic Cancer Cells" Thirteenth Buffalo Pharmaceutics Symposium, 323266818 (2014)
"Second-Generation Minimal PBPK Model for mAb Pharmacokinetics" 6th Annual Symposium Center for Protein Therapeutics, 323266818 (2014)
"3-day Course on Pharmacokinetics and Pharmacodynamics" University of Gdansk (2014)
"Minimal Physiologically-Based Pharmacokinetic Modeling of Monoclonal Antibodies" Servier Inc. (2014)
"Pharmacokinetics and Pharmacodynamics & Systems Pharmacology" Annual 4-day Buffalo Course on Pharmacokinetics and Pharmacodynamics & Systems Pharmacology (2014)
"PK/PD Modeling: Lessons from Corticosteroids" Medical University of Gdansk (2014)
"Workshop on Pharmacodynamics and Systems Pharmacology at Dublin City University" Dublin City University (2014)
"PK/PD Modeling of Anti-Infective Drugs" Hoffman LaRoche (2014)
"An Extensive and Reproducible Ion-Current-Based Method Enabled Large-Scale Proteomic Assessment of Corticosteroid Treatment in 60 Animals" American Association of Pharmaceutical Scientists (2013)
"Mechanism-Based Drug Interaction Model of Gemcitabine and Ecteinascidin (Et-743) in Pancreatic Cancer Cells" American Association of Pharmaceutical Scientists (2013)
"PK/PD Modeling in Inflammation" Department of Oral Biology, 323266818 (2013)
"Population Pharmacokinetics of Oral Baclofen in Pediatric Patients with Cerebral Palsy" Annual Meeting of the Child Neurology Society (2013)
"Profiling Diabetes Disease Progression in GK Rats and Intervention with Salsalate" American Association of Pharmaceutical Scientists (2013)
"Applications of Minimal PBPK Models in mAb Pharmacokinetics" 5th Annual Symposium Center for Protein Therapeutics (2013)
"Distribution of Etanercept to Sites of Inflammation in Collagen-Induced Arthritic Rats" 5th Annual Symposium Center for Protein Therapeutics, 323266818 (2013)
"Roles of FcgR in Pharmacokinetic Interactions of Immunosuppressants with mAb in Rheumatoid Arthritis" 5th Annual Symposium Center for Protein Therapeutics, 323266818 (2013)
"Pharmacokinetic-Pharmacodynamic Modeling" Genentech, Inc. (2013)
"CELL CYCLE MODELING OFFERS A PLATFORM TO OPTIMIZE COMBINATION OF CYTARABINE AND FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA" Congress of the European Hematology Association, 18th Congress of the European Hematology Association (2013)
"PHARMACODYNAMIC MODELING OF CELL CYCLE EFFECTS OF CYTARABINE AND FLT3 INHIBITORS ON ACUTE MYELOID LEUKEMIA CELLS" ASCPT 2013 Annual Meeting, ASCPT (2013)
"Applications of Minimal Physiologically-Based Pharmacokinetic Models" Research Institute of Pharmaceutical Sciences, Seoul National University (SNU) (2012)
"Moving PK/PD from Basic Towards Systems Pharmacology" 2012 International Conference of the Korean Society of Pharmaceutical Sciences and Technology (KSPST), KSPST (2012)
"Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics: Lessons From Corticosteroids" The Catholic University of Korea School of Medicine, Korean Society of Clinical Pharmacology and Therapeutics (2012)
"Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics: Lessons From Corticosteroids" Biomedical Research Institute, Chonnam National University Hospital (CNHU) (2012)
"Application of Minimal Physiologically-based Pharmacokinetic Models" 2012 AAPS Annual Meeting and Exposition, AAPS (2012)
"Mechanism-based Population Pharmacokinetic and Pharmacodynamic Modeling of Intravenous and Intranasal Dexmedetomidine" 2012 AAPS Annual Meeting and Exposition, AAPS (2012)
"Modeling Effects of Dexamethasone on Disease Progression of Bone Mineral Density in Collagen-induced Arthritic Rats" 2012 AAPS Annual Meeting and Exposition, AAPS (2012)
"Population Pharmacokinetics Analysis of Orally Administrated Baclofen in Pediatric Patients with Cerebral Palsy" 2012 AAPS Annual Meeting and Exposition, AAPS (2012)
"Proteome-level Pharmacokinetic/Pharmacodynamic Analysis of Corticosteroid-responsive Proteins in Rat Liver" 2012 AAPS Annual Meeting and Exposition, AAPS (2012)
"Extensive, proteome-level investigation of the corticosteroid pharmacodynamics with 12 time points using a reproducible and comprehensive ion-current-based profiling strategy" HUPO 2012 11th Annual World Congress, HUPO (2012)
"Moving PK/PD from Basic towards Systems Pharmacology" 2012 American College of Clinical Pharmacology (ACCP) Annual Meeting, American College of Clinical Pharmacology (2012)
"Pharmacokinetics/Pharmacodynamics/Pharmacogenomics: Lessons from Corticosteroids" 2012 American College of Clinical Pharmacology (ACCP) Annual Meeting, American College of Clinical Pharmacology (2012)
"Prednisone Dose and Exposure in Chronic Renal Transplant Recipients: One Size Does NOT Fit All" American Transplant Congress, American Transplant Congress (2012)
"Take it With Breakfast: But Does Food Reduce Prednisone Exposure As Much As It Reduces CNI Exposure in Renal Transplant Patients?" American Transplant Congress, American Transplant Congress (2012)
"Effects of sonic hedgehog inhibitor combined with nanoparticulate drug delivery on vascular permeability and efficacy in a pancreatic cancer model." Annual Meeting of the American Association for Cancer Research, American Association for Cancer Research (2012)
"Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine" 4th Annual UB Postdoc Research Symposium, University at Buffalo (2012)
"Multi-scale assessment of Everolimus and Sorafenib Combination in Pancreatic Cancer" American Association for Cancer Research, AACR (2012)
"Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats" 4th Annual UB Postdoc Research Symposium, University at Buffalo (2012)
"Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone Effects on iNOS mRNA Expression and Nitric Oxide During LPS-Induced Inflammation in Rats" 4th Annual UB Postdoc Research Symposium, University at Buffalo (2012)
"PK/PD/Disease Modeling in Cancer Chemotherapy" Hoffman La Roche, Hoffman La Roche (2012)
"What We Do in Pharmaceutical Sciences" UB Biology Honors Program (2012)
"Moving PK/PD From Basic Towards Systems Pharmacology" Rosa & Co. Impact of Modeling & Simulation in Drug Development Webinar, Rosa & Co. LLC. (2011)
"Population PK and PD Analysis of Oral Baclofen in Pediatric Patients with Cerebral Palsy" Pediatric Neurology Cerebral Palsy Center, Pediatric Neurology Cerebral Palsy Center (2011)
"Mechanistic Modeling of Tissue-specific Effects of Corticosteroids and Circadian Rhythms on Phosphoenolpyruvate Carboxykinase Expression in Rat Liver and Adipose Tissue" 2011 AAPS Annual Meeting and Exposition, AAPS (2011)
"Modeling Diabetes Disease Progression and Salsalate Intervention in Goto-Kakizaski Rats" 2011 AAPS Annual Meeting and Exposition, AAPS (2011)
"Modeling Pharmacokinetics/Pharmacodynamics of Abatacept and Disease Progression in Collagen-induced Arthritic Rats - A Population Approach" 2011 AAPS Annual Meeting and Exposition, AAPS (2011)
"Population Pharmacokinetic-Pharmacodynamic-Disease Progression Model for Effects of Anakinra in Lewis Rats with Collagen-induced Arthritis" 2011 AAPS Annual Meeting and Exposition, AAPS (2011)
"Population Physiologically-based Pharmacokinetic Models for Everolimus and Sorafenib in Pancreatic Cancer Xenograft Mice" 2011 AAPS Annual Meeting and Exposition, AAPS (2011)
"Systems Pharmacological Analysis of Molecularly Targeted Agents in Pancreatic Cancer: Pharmacodynamic Design of Novel Therapeutic Trials" Clinical and Translational Research Colloquium, University at Buffalo (2011)
"The Relevance of Chronobiology in PK/PD" 2011 AAPS Annual Meeting and Exposition, AAPS (2011)
"Pharmacokinetic/Pharmacodynamic/Disease Progression Model of Anakinra, an Interleukin-1 Receptor Antagonist, in Collagen-Induced Arthritic Rats" Third Annual Symposium Center for Protein Therapeutics, University at Buffalo (2011)
"Pharmacokinetic/Pharmacodynamic/Disease Progression Model of Effects of Abatacept in Collagen-Induced Arthritic Rats" Third Annual Symposium Center for Protein Therapeutics, University at Buffalo (2011)
"Assessment of L-Cell Function Based on GLP-1 Response in an Oral Glucose Tolerance Test" 2011 PAGE Meeting, PAGE (2011)
"Modeling type 2 diabetes progression in newly diagnosed patients" Post-Doctoral Fellowship Day, University at Buffalo (2011)
"PK/PD Modeling of Drug Effects in Inflammation" Bristol Myers Squibb, Bristol Myers Squibb (2011)
"Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis" Post-Doctoral Fellowship Day, University at Buffalo (2011)
"Genome-wide analysis of circadian oscillations in gene expression in lung and its implications in lung homeostasis, repair and diseases" EXPERIMENTAL BIOLOGY 2011, APS (2011)
"Modeling Diabetes Progression in Goto-Kakizaki Rat and Salsalate Intervention" Pharmaceutical Sciences Poster Day, University at Buffalo (2011)
"Physiologically-Based Pharmacokinetics and Interactions of Everolimus and Sorafenib in Mice" American Association for Cancer Research, AACR (2011)
"Mechanism-Based PK/PD Model of Pramlintide in Patients with Type 1 Diabetes" AAPS Annual Meeting and Exposition, AAPS (2010)
"Modeling chemotherapeutic interactions of sorafenib and everolimus effects on pancreatic cancer cells" AAPS Annual Meeting and Exposition, AAPS (2010)
"Pharmacodynamic Interaction of Everolimus and Sorafenib Using In Vitro Whole Blood Lymphocyte Proliferation" AAPS Annual Meeting and Exposition, AAPS (2010)
"Pharmacokinetic - Pharmacodynamic - Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis" AAPS Annual Meeting and Exposition, AAPS (2010)
"Pharmacokinetic-Pharmacodynamic-Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis" AAPS Annual Meeting and Exposition, AAPS (2010)
"Pharmacokinetics and Pharmacodynamics of Rosiglitazone in Type 2 Diabetic Goto-Gakizaki (GK) Rats" AAPS Annual Meeting and Exposition, AAPS (2010)
"The Development of Mechanistic Population Pharmacokinetic Models to Support the Development of Targeted Release Characteristics from Modified Release Dosage Forms" AAPS Annual Meeting and Exposition, AAPS (2010)
"Department Highlights & Introduction and Historical Perspectives of PK/PD" 12th Buffalo Pharmaceutics Symposium, University at Buffalo (2010)
"Pharmacokinetic/Pharmacodynamic modeling of GLP-1 in healthy rats" 12th Buffalo Pharmaceutics Symposium, University at Buffalo (2010)
"PK/PD Modeling of Etanercept" Meeting of the Center for Protein Therapeutics (2010)
"Pediatric Pharmacokinetics: Lithium, Baclofen, and Hydroxyurea" 2010 Best Pharmaceuticals for Children Act Annual Meeting, National Institute of Child Health and Human Development & National Institutes of Health (2010)
"Pharmacokinetic - Pharmacodynamic - Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis" Annual Pharmaceutics Graduate Student Research Meeting (2010)
"Pharmacokinetics and Pharmacodynamics of Anti-CD3 Monoclonal Antibody, Otelixizumab in Subjects with Diabetes and Psoriasis" The Annual Meeting of the Population Approach Group in Europe, Population Approach Group in Europe (2010)
"Pharmacodynamic Interaction of Everolimus and Sorafenib Using In Vitro Whole Blood Lymphocyte Proliferation" Pharmacology Day 2010, University at Buffalo (2010)
"Target-Mediated Pharmacokinetic Modeling of Exendin-4 Disposition in Rats, Monkeys and Humans" Pharmacology Day 2010, University at Buffalo (2010)
"Various" Annual Course in PK/PD Modeling, University at Buffalo (2010)
"Research Perspectives of the UB Department of Pharmaceutical Sciences" SUNY Upstate Cancer Research Institute Workshop, SUNY Upstate Cancer Research Institute (2010)
"Systems Pharmacology of Anti-Inflammatory Effects of Corticosteroids" Mount Sinai School of Medicine Workshop, Mount Sinai School of Medicine (2010)
"PK/PD Modeling of Anti-Inflammatory Drug Effects" Drug Metabolism Department at Hoffman La Roche, Hoffman La Roche (2010)
"Assessing Drug Accumulation and Half-Lives During Multiple-Dosing Conditions" Annual Meeting of AAPS, AAPS (2009)
"Comparison of Liver and Muscle Genes for Presence of Circadian Rhythms" Annual Meeting of AAPS, AAPS (2009)
"Population Pharmacokinetic-Pharmacodynamic Model for the Triglyceride Lowering Effect of a PPAR Agonist: A Phase I Study" Annual Meeting of AAPS, AAPS (2009)
"Role of Sex (Gender) in Drug Kinetics and Dynamics" Frontier Science and Technology Research Foundation, Frontier Science and Technology Research Foundation (2009)
"Target-Mediated Pharmacokinetic Modeling of Exendin-4 Disposition in Rats, Monkeys and Humans" Annual Meeting of AAPS, AAPS (2009)
"Pharmacokinetic/Pharmacodynamic Modeling of Glucose Clamp Effects of Inhaled Insulin" American Conference on Pharmacometrics, ACoP (2009)
"Population PK/PD Modeling of the Effects of Vildagliptin on Active GLP-1, Glucose, and Insulin" American Conference on Pharmacometrics, ACoP (2009)
"Disease Progression Model in Type 2 Diabetic Rats" Pharmacology Day 2009 (2009)
"Disease Progression Model in Type 2 Diabetic Rats" Pharmacology Day 2009 (2009)
"Gene Expression as a Pharmacodynamic Marker" AAPS Workshop on Translational Biomarkers (2009)
"Mechanism-Based PK/PD Model of Pramlintide in Type 1 Diabetic Patients" Pharmacology Day 2009 (2009)
"Methods of Utilizing Baseline Values for Indirect Response Models" Pharmacology Day 2009 (2009)
"Model-Based Comparison of Binocrit and Erypo Pharmacokinetics after Repeated I.V. and S.C. Administration" WCN (World Congress of Nephrology) (2009)
"Role of Sex/Gender in Drug Kinetics and Dynamics" City-Wide Grand Rounds, Erie County Medical Center (2009)
"Systems pharmacology of anti-inflammatory effects of corticosteroids" Experimental Biology 2009 Meeting (2009)
"Animal Scaling of Pharmacokinetics and Pharmacodynamics" , Hoffman-LaRoche (2009)
"Pharmacokinetic and Pharmacodynamic Modeling of Anti-inflammatory Drugs" , Hoffman-LaRoche (2009)
"Disease Progression Model in Type 2 Diabetic Goto-Kakizaki Rats" American Association of Pharmaceutical Sciences Meeting (2008)
"Mechanism-Based Modeling of Leptin Production and Effect on Food Intake in Normal Wistar (CON) and Type 2 Diabetic Goto-Kakizki Rats (GK) on Different Diets" American Association of Pharmaceutical Sciences Meeting (2008)
"Mechanism-Based Pharmacokinetic Pharmacodynamic (PKPD) Model for the Inverse Inoculum Effect of Imipenem Against Psedomonas Aeruginosa" American Association of Pharmaceutical Sciences Meeting (2008)
"Modeling Sitagliptin Effects on Glucagon-Like Peptide 1 (GLP-1) and Glucose in Type 2 Diabetic Patients (T2DM)" American Association of Pharmaceutical Sciences Meeting (2008)
"Bioequivalence of Biosimilars - Is Pharmacodynamic Equivalence Sufficient?" Ehrlich II -2nd World Conference on Magic Bullets Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich (2008)
"Corticosteroids - Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, and Disease Progression" Ehrlich II -2nd World Conference on Magic Bullets Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich (2008)
"First-Dose Pharmacokinetics of Lithium Carbonate in Children and Adolescents" Annual Meeting of the American Academy of Child and Adolescent Psychiatry, AACAP (2008)
"Pharmacokinetic Pharmacodynamic Concepts" Ehrlich II -2nd World Conference on Magic Bullets Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich (2008)
"Exposure-Response Modeling" Land O'Lakes Conference on Drug Metabolism/Applied Pharmacokinetics, University of Wisconsin (2008)
"Multiple-Pool Lifespan Models for Neutropenia to Assess the Population Pharmacodynamics of Unbound Paclitaxel from Two Formulations in Cancer Patients" Quantitative and Systems Pharmacology Workshop, National Institute of General Medical Sciences (2008)
"Population PK/PD Modeling of Inhibition of Dipeptidyl Peptidase IV" Quantitative and Systems Pharmacology Workshop, National Institute of General Medical Sciences (2008)
"Systems PK/PD/PG/DIS model for anti-inflammatory effects of corticosteroids" Quantitative and Systems Pharmacology Workshop, National Institute of General Medical Sciences (2008)
"Utility of PK/PD modeling in drug development & PK/PD modeling of anti-inflammatory drugs." Merial Pharmaceuticals, Merial Pharmaceuticals (2008)
"Erythropoietin Receptor-Mediated Disposition and Dynamic Model for Human Recombinant Erythropoietin (rHuEPO)" AAPS Annual Meeting (2007)
"Characterization and application of a new model for the assessment of non-competitive drug-drug interactions" AAPS Annual Meeting (2006)
"Development of mathematical model for chemotherapy-induced anemia in rats and its application to selection of rHuEPO dosing strategy" AAPS Annual Meeting (2006)
"Population pharmacokinetic and pharmacodynamic modeling of a novel erythropoietin receptor agonist, HematideTM, in healthy volunteers" , AAPS Annual Meeting (2006)
University of Buffalo, Search Committee for Dean, School of Pharmacy; Committee Member (2013)
E Fund Proposal Review Committee; Committee Member (2012)
Advisory Committee, Center for Clinical and Translational Research Grant Application; Committee Member (2012–2015)
Pilot Studies Oversight Review Committee; Committee Member (2012)
Committee; AAPS/AACP NIH Research Task Force; Committee Member (2011)
VPR External Advisory Committee; Medical College of Wisconsin; Committee Member (2011–2014)
External Reviewer, Promotion; Rutgers University, New Jersey; External Reviewer (2011)
External Reviewer, Promotion; Eschelman School of Pharmacy, University of North Carolina; External Reviewer (2011)
NIDDK - National Institute of Diabetes and Kidney Diseases Special Emphasis Panel; NIDDK - Grant Applicatins; Panel Member (2011)
Program Project: Mechanisms of Drug Disposition During Pregnancy; NIH - Program Project Grant Applications: Mechanisms of Drug Disposition During Pregnancy; Panel Member (2011)
NIH Committee Meeting - Bethesda, MD; Quantitative and Systems Pharmacology; Committee Member (2010)
Special Emphasis Panel; NIGMS; Panel Member (2009)
Reviewer; National Institute of Diabetes and Digestive and Kidney Diseases; Reviewer (2009)
International Scientifica Advisory Board; 6th International Symposium on Measurement and Kinetics of In Vivo Drug Effects, The Netherlands; Advisory Board (2009)
Planning Committee; Translational Biomarkers for Accelerating Drug Development: From Preclinical to Clinical; Committee Member (2009)
Special Emphasis Panel; NIGMS; Panel Member (2009)
SUNY Distinguished Service Review Committee; Committee Member (2008)
Organizing Committee; AAPS Workshop on Biomarkers and Drug Development; Committee Member (2008)
MRBS Faculty Committee; Committee Member (2007)
Organizing Committee; Workshop on Pharmacology and Systems Biology; Committee Member (2007)
Selection Committee; Volwiler Award, Am Assn Coll Pharmacy; Committee Member (2006–2008)
School of Pharmacy Awards Committee; Committee Member (2005)
Executive Committee; Committee Member (2001–2016)
School Promotions and Tenure Committee; Committee Member (2001–2016)
School News:
In the Media:
Clinical Specialties:
Clinical Offices:
Insurance Accepted:
Contact Information
404 Pharmacy Building Buffalo, NY 14214-8033 Phone: (716) 645-2855 Fax: 7168296569 wjjusko@buffalo.edu